ZyVersa Therapeutics (ZVSA) went public on December 12, 2022, when it opened at a split-adjusted price of $3,500.
| DATE | OPEN | HIGH | LOW | CLOSE | VOLUME |
|---|---|---|---|---|---|
November 2024 | $2.01 | $3.37 | $1.03 | $1.07 | 71,872,300 |
October 2024 | $2.45 | $2.45 | $1.90 | $2.01 | 5,802,580 |
September 2024 | $2.80 | $2.91 | $2.08 | $2.40 | 1,539,600 |
August 2024 | $3.56 | $3.96 | $2.61 | $2.76 | 2,129,000 |
July 2024 | $3.65 | $6.30 | $3.40 | $3.46 | 5,686,439 |
June 2024 | $4.68 | $5.35 | $3.41 | $3.76 | 1,184,000 |
May 2024 | $5.16 | $6.69 | $3.94 | $4.94 | 2,856,500 |
April 2024 | $7.50 | $8.05 | $4.44 | $5.29 | 9,293,070 |
March 2024 | $10.70 | $11.80 | $7.09 | $7.50 | 2,194,160 |
February 2024 | $5.80 | $25.00 | $5.40 | $11.00 | 12,617,110 |
January 2024 | $9.20 | $9.80 | $5.00 | $5.70 | 2,246,030 |
December 2023 | $21.35 | $30.30 | $6.75 | $9.00 | 3,054,109 |
November 2023 | $37.10 | $42.35 | $21.00 | $22.75 | 395,872 |
October 2023 | $45.50 | $62.30 | $25.90 | $28.70 | 289,208 |
September 2023 | $48.30 | $79.80 | $38.50 | $45.50 | 680,069 |
August 2023 | $59.15 | $61.25 | $45.50 | $49.70 | 47,648 |
July 2023 | $87.15 | $115.15 | $56.35 | $60.55 | 174,480 |
June 2023 | $133.00 | $147.00 | $84.00 | $86.10 | 87,663 |
May 2023 | $171.50 | $220.85 | $126.35 | $128.10 | 170,545 |
April 2023 | $668.50 | $906.50 | $149.10 | $162.75 | 75,298 |
March 2023 | $773.50 | $969.50 | $551.25 | $675.50 | 32,216 |
February 2023 | $665.00 | $1,043.00 | $602.00 | $770.00 | 18,258 |
January 2023 | $591.50 | $1,533.00 | $542.50 | $644.00 | 39,880 |
December 2022 | $3,556.00 | $8,750.00 | $483.00 | $549.50 | 4,659 |
November 2022 | $3,510.50 | $3,633.00 | $3,510.50 | $3,556.00 | 634 |
